Literature DB >> 30623205

[Innovative care models for people with schizophrenia].

Martin Lambert1, Vivien Kraft2, Anja Rohenkohl2, Friederike Ruppelt2, Romy Schröter2, Daniel Lüdecke2, Birgit Linschmann2, Simon Eich2, Lisa Tlach2, Despina Lion2, Susann Bargel3, Martin Hoff3, Gunda Ohm3, Michael Schulte-Markwort4, Daniel Schöttle2, Hans-Helmut König5, Holger Schulz6, Judith Peth6, Jürgen Gallinat2, Anne Karow2.   

Abstract

Schizophrenia is a complex mental disorder. Hence, the mental health system faces enormous structural, therapeutic, and health-economic challenges. Innovative models of healthcare can facilitate making treatment more efficient and effective.This paper aims to give an overview of evidence-based and innovative models of care and treatment for schizophrenia and severe mental illnesses. For this purpose, we performed a literature search covering the last 10 years of publications regarding "care or treatment models" and "schizophrenia," "psychosis," or "severe mental illness."Many publications do not provide details about the tested care model. Innovative care models for schizophrenia comprise early psychosis services (EPSs) or models for severe mental illnesses (SMI) integrating, combining and/or developing the treatment models crisis resolution team (CRT), assertive community treatment (ACT), and/or (intensive) case management (ICM). For illustration, the innovative models Early Psychosis Prevention and Intervention Centre (EPPIC) in Australia, the Flexible Assertive Community Treatment model in the Netherlands, and the Therapeutic Assertive Community Treatment model in Hamburg are explained. All three models regularly offer integrated, specialized, and assertive care.In Germany, innovative models of care have not been implemented sufficiently: neither EPS nor ACT are part of standard care; CRT can now be funded by health insurances via "ward-equivalent treatment" as defined by a new German law (§§ 39 und 115d SGB V). Regarding the implementation of CRT and ACT in Germany, a clinical study evaluating the RECOVER model is underway. This is a stepped-care, trans-sectorally coordinated and evidence-based treatment model, the evaluation of which is supported by the innovation fund of the Joint Federal Committee (Gemeinsamen Bundesausschuss, G‑BA) from 2017 to 2020.

Entities:  

Keywords:  Bipolar disorder; Care models; Integrated care; Schizophrenia; Severe mental illness

Mesh:

Year:  2019        PMID: 30623205     DOI: 10.1007/s00103-018-2868-y

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  4 in total

Review 1.  [Healthcare research in the living environment].

Authors:  Martin Lambert; Anne Karow; Jürgen Gallinat
Journal:  Nervenarzt       Date:  2019-11       Impact factor: 1.214

Review 2.  Models of Care of Schizophrenia in the Community-An International Perspective.

Authors:  Guru S Gowda; Mohan K Isaac
Journal:  Curr Psychiatry Rep       Date:  2022-03-01       Impact factor: 5.285

3.  Study protocol for a randomised controlled trial evaluating an evidence-based, stepped and coordinated care service model for mental disorders (RECOVER).

Authors:  Martin Lambert; Anne Karow; Jürgen Gallinat; Daniel Lüdecke; Vivien Kraft; Anja Rohenkohl; Romy Schröter; Constanze Finter; Anna-Katharina Siem; Lisa Tlach; Nathalie Werkle; Susann Bargel; Gunda Ohm; Martin Hoff; Helmut Peter; Martin Scherer; Claudia Mews; Susanne Pruskil; Johannes Lüke; Martin Härter; Jörg Dirmaier; Michael Schulte-Markwort; Bernd Löwe; Peer Briken; Heike Peper; Michael Schweiger; Mike Mösko; Thomas Bock; Martin Wittzack; Hans-Jochim Meyer; Arno Deister; Rolf Michels; Stephanie Herr; Alexander Konnopka; Hannah König; Karl Wegscheider; Anne Daubmann; Antonia Zapf; Judith Peth; Hans-Helmut König; Holger Schulz
Journal:  BMJ Open       Date:  2020-05-04       Impact factor: 2.692

4.  The Efficacy of Extended Metacognitive Training on Neurocognitive Function in Schizophrenia: A Randomized Controlled Trial.

Authors:  Can Wang; Yue Chong; Jiechun Zhang; Yili Cao; Yanbo Wang
Journal:  Brain Sci       Date:  2022-03-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.